Atlas Trials

the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy

Clinical trial NCT05485558 · COMPLETED

Trial details

NCT number
NCT05485558
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Drug Resistant Epilepsy
Start date
2022-09-15
Primary completion
2024-06-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.